Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessing Pain and Effectiveness of Carevix Device for IUD Insertions

NCT: NCT07290517 · RECRUITING

NCT IDNCT07290517
StatusRECRUITING
Start Date2026-03-11
Completion2027-03
SponsorIndiana University (OTHER)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to evaluate patient-reported pain, bleeding, and device efficiency along with provider satisfaction and ease of use between IUD insertions using a suction cervical stabilizer (new device, FDA approved, atraumatic) and single-tooth tenaculum (standard, traumatic). Our aims are to: * assess and compare patient-reported pain during IUD insertion between the Carevix device and tenaculum. * assess predictors of pain scores including between nulliparous and multiparous patients * assess provider-reported ease of use and satisfaction Participants (including providers) will: * be randomized to receive one device to complete the IUD procedure * complete a survey following the procedure

Frequently Asked Questions

What is Assessing Pain and Effectiveness of Carevix Device for IUD Insertions?

Assessing Pain and Effectiveness of Carevix Device for IUD Insertions is a clinical trial registered under NCT07290517. Current status: RECRUITING.

What is the status of NCT07290517?

The current status of NCT07290517 (Assessing Pain and Effectiveness of Carevix Device for IUD Insertions) is: RECRUITING.

When did Assessing Pain and Effectiveness of Carevix Device for IUD Insertions start?

Assessing Pain and Effectiveness of Carevix Device for IUD Insertions started on 2026-03-11.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.